Beranda › Kanker Payudara › Virginia › Arlington
Uji klinis Kanker Payudara di Arlington, VA
47 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauhnya
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Menerima pesertaFase 3
- Virginia Cancer Specialists, PC, Fairfax · 11 mi jauhnya
A Study of PHST001 in Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi jauhnya
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Menerima pesertaFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Menerima pesertaFase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Virginia Cancer Specialists, PC, Fairfax · 11 mi jauhnya
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Menerima pesertaFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Menerima pesertaFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
Study of AVZO-021 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi jauhnya
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Menerima pesertaFase 3
- Inova Schar Cancer Institute ( Site 0025), Fairfax · 11 mi jauhnya
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Menerima pesertaFase 3
- Research Site, Fairfax · 11 mi jauhnya
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Menerima pesertaFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Menerima peserta
- Inova, Fairfax · 11 mi jauhnya
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Menerima pesertaFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
Menerima pesertaFase 1
- Next Virginia, Fairfax · 11 mi jauhnya
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Menerima pesertaFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Menerima pesertaFase 1/2
- Next Oncology, Fairfax · 11 mi jauhnya
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Menerima pesertaFase 1/2
- Virginia Cancer Specialists-Fairfax, Fairfax · 11 mi jauhnya
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi jauhnya
- Kaiser Permanente-Burke Medical Center, Burke · 11 mi jauhnya
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Menerima pesertaFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mi jauhnya
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauhnya
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Menerima pesertaFase 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- Inova Fairfax Hospital, Falls Church · 4 mi jauhnya
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi jauhnya
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
- dan 1 lainnya
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauhnya
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Menerima pesertaFase 3
- INOVA Schar Cancer, Fairfax · 11 mi jauhnya
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- NEXT, Fairfax · 11 mi jauhnya
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Menerima pesertaFase 1/2
- Inova Schar Cancer Institute ( Site 0051), Fairfax · 11 mi jauhnya
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Menerima pesertaFase 3
- Virginia Cancer Specialists, PC, Reston · 14 mi jauhnya
- Virginia Cancer Specialists, Manassas · 22 mi jauhnya
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- NEXT, Virginia, Fairfax · 11 mi jauhnya
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Menerima pesertaFase 1
- Inova Schar Cancer Center, Fairfax · 11 mi jauhnya
- NEXT Virginia, Fairfax · 11 mi jauhnya
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Menerima pesertaFase 1
- Biotheryx Investigative Site, Fairfax · 11 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Arlington
- Kanker Paru Non-Sel Kecil104 studi
- Kanker Metastatik53 studi
- Kanker Kolorektal52 studi
- Kanker (semua jenis)48 studi
- Kanker Ovarium46 studi
- Kanker Paru41 studi
- Kanker Endometrium39 studi
- Kanker Pankreas33 studi
- Karsinoma Sel Skuamosa Kepala dan Leher26 studi
- Kanker Paru Sel Kecil23 studi
- Kanker Lambung20 studi
- Kanker Payudara Triple-Negatif20 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.